An Evaluation of Maternal Position During Cesarean Delivery
NCT ID: NCT02872181
Last Updated: 2018-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2016-04-30
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supine Versus Left Lateral Tilted Position During Cesarean Delivery
NCT03182114
Hemodynamic Effect of Left Tilting in Cesarean Delivery
NCT03181776
Effect of Different Left Lateral Table Tilt for Elective Cesarean Delivery Under Spinal Anesthesia
NCT04083768
Measurement of Hemodynamic Variables Under Spinal Anesthesia With Varied Positioning
NCT02883075
Effect of Position During Spinal Anesthesia on Hemodynamic Change in Cesarean Section
NCT02253381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BMI <30
Pregnant women undergoing C/S with BMI \<30
Supine
Placed in Supine position
Left uterine displacement
Placed in 15 degrees left uterine displacement
BMI 30-40
Pregnant women undergoing C/S with BMI 30-40
Supine
Placed in Supine position
Left uterine displacement
Placed in 15 degrees left uterine displacement
BMI >40
Pregnant women undergoing C/S with BMI \>40
Supine
Placed in Supine position
Left uterine displacement
Placed in 15 degrees left uterine displacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supine
Placed in Supine position
Left uterine displacement
Placed in 15 degrees left uterine displacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years old
* ASA 1 and 2 (i.e., patient is completely healthy (1) or has mild systemic disease (2)
* Able and willing to consent to participate
Exclusion Criteria
* \<18 years old
* maternal cardiac/pulmonary/hematologic disorders/renal failure
* drug/alcohol/tobacco use during pregnancy
* essential or pregnancy-induced hypertension
* diabetes greater than 10 years
* pre-eclampsia or abruptio placenta
* \<37 weeks gestation
* hemoglobin \< 7 g/dL
* intrauterine growth retardation
* fetal distress or fetal anomaly
* Transverse lie
* Ruptured membranes
* Severe polyhydramnios or oligohydramnios
* Multiple gestation
* severe scoliosis or kyphosis,
* uterine abnormalities (e.g., large fibroids, bicornuate uterus)
* Failed spinal (sensory level \< T6 after 15 minutes)
* need to convert to general anesthesia before delivery
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hartford Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
adam sachs, MD
Role: PRINCIPAL_INVESTIGATOR
Hartford Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hartford Hospital
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HartfordH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.